Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8770
+0.0017 (0.19%)
At close: Apr 16, 2026, 4:00 PM EDT
0.8898
+0.0128 (1.46%)
After-hours: Apr 16, 2026, 6:28 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $31.96 million as of April 16, 2026. Its market cap has decreased by -21.29% in one year.
Market Cap
31.96M
Enterprise Value
29.70M
1-Year Change
-21.29%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $31.96M, a decrease of -66.29%. That is a compound annual growth rate of -14.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 31.90M | -6.18% |
| Dec 31, 2025 | 34.00M | -34.36% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 33.81M |
| ABVC BioPharma | 33.61M |
| INmune Bio | 33.50M |
| BriaCell Therapeutics | 33.04M |
| Longeveron | 32.79M |
| Apollomics | 32.64M |
| Tempest Therapeutics | 32.27M |
| Palatin Technologies | 31.42M |